As per our research report, the global Immunology Market size was USD 10121 million in 2022 and is estimated to grow to USD 14901 million by 2030. This market is witnessing a healthy CAGR of 8.85% from 2023 - 2030. Innovations and developments in the immunological technologies focused on exploring the application, The surge in the prevalence rate of the different types of cancer and rheumatoid cancer, rising government initiatives, and increasing funding from the various government and non-government organizations are majorly driving the growth of the industry.
The immune system is a set of structures and processes within the body that protect against foreign bodies and potentially harmful diseases. It identifies various threats such as bacteria, viruses, and parasites and distinguishes them from healthy body tissues.
When the immune system weakens and loses its ability to detect and destroy abnormal cells or attacks the body and damages its tissues, this leads to diseases such as cancer and autoimmune diseases. Immunotherapy is a process that includes treatment by inducing, strengthening, or suppressing the immune system to fight disease.
According to the American Association of Autoimmune Diseases, autoimmune diseases affect 50 million Americans. There are 80 types of autoimmune diseases, of which the most common are rheumatoid arthritis, systemic lupus erythematosus (lupus), juvenile rheumatoid arthritis, enterocolitis, psoriatic arthritis, and affect the muscles. various organs of the body such as joints, muscles, skin, red blood cells, blood vessels, connective tissue, and endocrine glands.
Immunopharmaceuticals are becoming the choice of many oncologists because they provide long-term effects by activating the immune system to identify cancer cells and destroy them through a natural process of coagulation. while improving the quality of survival. Several FDA-approved cancer vaccines, bacille CalmetteGuérin (BCG), and SipuleucelT promote the growth of the immunotherapy market. Immunology is a branch of medicine and biology that studies the immune system. The immune system protects us against infection in many different ways. Diseases such as autoimmune, allergies, and cancer can occur when a person's immune system does not work properly. Autoimmune diseases occur when the immune system attacks the body it is supposed to protect. People with autoimmune diseases have defects that prevent their immune systems from distinguishing "self" from "selfless" or "foreign" molecules. Immunology offers a variety of laboratory tests to detect autoimmune diseases.
MARKET DRIVERS
Recent product approvals by regulatory agencies is estimated to drive the growth of the market
New drug approvals and trends in clinical improvement bode well for the global immunology industry. For example, the Food and Drug Administration (FDA) authorized AbbVie to use "SKYRIZI" in 2022. The drug was developed to treat moderate to severe plaque psoriasis. This medication is designed to treat adults with psoriasis who have been prescribed or are being treated.
An increase in the Number of Various diseases such as cancer and others is also driving the growth of the market
The increase in the prevalence of various types of cancer and rheumatoid cancer, increase in government initiatives, and increase in funding from various governmental and non-governmental organizations are driving the market of immunosuppressive drugs. Translate. Patients with a poor prognosis are estimated to stimulate the development of immunology. Evidence from trials shows that after preparing the immune system to fight cancer, the effects of the drug last even after the tumor has shrunk.
MARKET RESTRAINTS
High Cost Associated with the treatment is restraining the growth of the market
The high cost of immunology drugs, side effects associated with these drugs and lack of awareness are the key factors that may hinder the growth of the global immunology market. For example, according to data reported by the New York Times from SSR Health, a research firm, the price of Humira (a prescription injectable drug used to treat rheumatoid arthritis and other conditions) has increased from approximately $19,000 USD per year (in 2012) over US$38,000 per year (2022) per patient.
Market Segmentation
This research report on the Immunology market has been segmented and sub-segmented based on the following categories:
On the basis of drug classes, the global immunology market is segmented into monoclonal antibodies, fusion proteins, immunosuppressants, and polyclonal antibodies. Monoclonal antibodies are antibodies produced by identical immune cells, all of which are copies of a parent cell. Monoclonal antibodies can have monovalent affinity, where they bind to the same epitope. Monoclonal antibodies are used to enhance and suppress the immune response in various pathologies such as cancer, cardiovascular and cerebrovascular which increase the demand for monoclonal antibodies. Fusion proteins are created by joining two or more genes that initially code for separate proteins.
Naturally, fusion proteins are commonly found in cancer cells, where they can function as oncoproteins. Factors such as those used for AIDS clearance, and the increasing application of fusion proteins, which are more stable and soluble in host cells compared to native proteins, drive the need for fusion proteins in the forecast period. Immunosuppressants are a group of drugs that suppress the strength of the body's immune system. Some of these drugs are used to make the body able to reject a transplanted organ, such as a liver, heart, or kidney. These drugs are called antirejection drugs.
The main factors driving the need for immunosuppressive drugs are complications associated with organ transplantation, such as the recipient's body recognizing the transplanted organ or tissue as foreign and causing a transfusion reaction. Polyclonal antibodies are antibodies produced by different lines of B cells in the body. It is a collection of immunoglobulin molecules that react against a specific antigen, each defining a different epitope. Тhе polyclonal аntіbоdу segment іѕ growing оwіng tо thе fаvоrаblе есоnоmіс еnvіrоnmеnt, rоbuѕt grоwth of thе рhаrmасеutісаlѕ іnduѕtrу, inсrеаѕе rеѕеаrсh асtіvіtіеѕ іn lіfе ѕсіеnсеѕ іnduѕtrіеѕ, and grоwіng рrоtеоmісѕ аnd gеnоmісѕ rеѕеаrсh.
In terms of disease indications, the global immunology market is segmented into rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and transplant rejection prophylaxis. Rheumatoid arthritis is an autoimmune disease caused by the immune system attacking the body's healthy tissues. The immune system normally produces antibodies that attack bacteria and viruses, helping to fight infections. Rheumatoid factor blood tests help diagnose rheumatoid arthritis. Rheumatoid factor is an antibody that can be detected in the blood of about 80% of adults with rheumatoid arthritis. Rheumatoid factor testing is used by healthcare professionals to help diagnose rheumatoid arthritis. The prevalence of rheumatoid arthritis, a growing aging population, and orthopedic disorders are estimated to drive demand for rheumatoid arthritis testing kits.
Psoriatic arthritis is a form of arthritis that affects people with psoriasis, a condition characterized by red patches of skin with silvery scales. Most people develop psoriasis first and are later diagnosed with psoriatic arthritis, but joint problems can sometimes begin before the patches appear. Blood tests may be done to check for signs of inflammation. These include C-reactive protein and rheumatoid factor. People with psoriatic arthritis are nearly RF negative. There is a significant paradigm shift in the treatment of psoriatic arthritis, due to the targeted effects of biologics, the emergence of biological lenses, and consumer demand for effective drugs. on cost with improved safety. Ankylosing spondylitis is an inflammatory disease that over time can cause some of the small bones in the spine to fuse together. This fusion makes the spine less flexible and can lead to a forward-curved posture. The HLAB27 test is primarily indicated to help support or confirm a suspected diagnosis of ankylosing spondylitis.
Demand for ankylosing spondylitis test kits is estimated to increase during the forecast period due to increased spending on research and development, an increasing number of people seeking treatment, and unmet demand. current treatment on appropriate medications. Individuals undergoing organ transplantation should be maintained long-term on an immunosuppressive regimen to prevent rejection to help ensure graft survival. Organ rejection prevention is associated with the prevention of tissue/transplant rejection in patients who have undergone an organ transplant procedure. Increased risk factors for organ damage such as trauma, an increase in diseases such as diabetes, high blood pressure, and stroke are driving large numbers of patients to organ transplants, and the rate of organ donation by recipients Increased awareness is a major factor driving the need to prevent transplant rejection.
Geographically North America holds the largest share of the global immune pharmaceuticals market due to better reimbursement policies, high potential to invest large sums in immunotherapy drug development, and technological advancements.
Europe is the second-largest region in terms of value due to easy access to immunotherapy and the high affordability of treatment. Increased awareness, growing economy, increase in government initiatives and large patient population in Asia-Pacific regions also indicate higher growth of the drug market immunity In the global immunology market.
Immunology Market Share by company
Companies like AbbVie Inc., Janssen Global Services, Johnson & Johnson, F. Hoffmann-La Roche Ltd, Amgen Inc., Pfizer Inc., Novartis, Astellas, Bristol-Myers Squibb Company, Merck Sharp & Dohme Corp., UCB SA, and Allergan plc. and others are playing a pivotal role in the market.
Recently Johnson & Johnson and its Janssen Pharmaceutical Companies plan to launch or file for regulatory approval more than 10 new products with “blockbuster potential” over the next by the end of 2022. With a growing core business of differentiated medicines and a strong line-up of innovative products estimated to launch or file over the next five years, Johnson and Johnson are leading the industry in advancing the health of patients around the world.
Suppliers invest in research and development to develop technologically advanced systems that give them a competitive advantage over other providers and provide an economic benefit to the industry. The industry is estimated to see several mergers and acquisitions over the next few years. Companies are taking proactive steps to gain market share and provide a diversified product portfolio.
NOTABLE HAPPENINGS IN THE IMMUNOLOGY MARKET IN THE RECENT PAST:
Agreement - In April 2022, ImaginAb and [Yantai] Dongcheng Pharmaceutical Group Sign Exclusive License Agreement to Commercialize CD8 ImmunoPET Agent in China to Serve Pharma and Healthcare Community.
Collaboration - In April 2022, AbbVie, Inc. announced the acquisition of Allergan Plc with an aim to expand its presence and strengthen its position in the pharmaceuticals sector across the globe.
COVID-19 impact on Immunology Market
Since the outbreak of the COVID19 virus in December 2022, the disease has spread to more than 100 countries around the world and the World Health Organization has declared it a public health emergency in 2022. According to the World Health Organization's Weekly Epidemiology of Coronavirus Disease (COVID19) Update, the number of COVID19 cases reported worldwide as of August 2, 2022, is approximately 198,234,951 confirmed cases with approximately 4,227,359 deaths. The Coronavirus or COVID19 outbreak started in Wuhan, China, and has spread across continents affecting many different industries around the world.
The negative effects of the global pandemic, COVID19, have been felt in a number of economies that are facing unprecedented losses, this is due to the embargo of government agencies, thus Several industries have been suspended with restricted activity activities. However, a collective effort by government and industry could possibly put the economy on track and help industrial activity resume. New drug approvals and trends in clinical improvement bode well for the global immunology industry. For example, the Food and Drug Administration (FDA) authorized AbbVie to use "SKYRIZI" in 2022. The drug was developed to treat moderate to severe plaque psoriasis. This medication is designed to treat adults with psoriasis who have been prescribed or are being treated.
Global automotive lighting refers to all vehicle lighting systems, from headlamps that illuminate the road to taillights that communicate movements. They guarantee motorists and other road users alike safety, visibility, and style. While taillights frequently use LEDs for improved visibility, headlights are available in a variety of technologies, including LED and laser. Interior illumination, DRLs, and signal lights all have a role to play. This market, which was estimated to be worth $33.64 billion in 2022, is anticipated to rise to $67.39 billion by 2030 because of laws, luxury tastes, safety concerns, and technological developments like OLED taillights and adaptive headlights. Anticipate a future dominated by intelligent, connected, personalized, and sustainable lighting systems that enhance the safety, efficiency, and aesthetic appeal of automobiles.
Car lighting works its magic to provide safety, visibility, and style. Headlights cut through the night, taillights express intent, and interiors shine with comfort. The billion-dollar global business is expected to rise due to consumer demand for high-end experiences, safer roads, and cutting-edge technology. Imagine dynamic messages being painted by taillights, headlights that adjust to the road, and interiors that customize their atmosphere. Driven by technological advancements like linked systems and laser beams, this future is calling. Anticipate even more visually attractive, environmentally friendly, and intelligent lighting to illuminate the way ahead, making cars safer, more efficient, and unquestionably cooler.
In the market for automobile lighting, safety is the driving force behind demand from the public and laws. While automated high beams smoothly react to traffic, adaptive headlights modify their beams so as not to blind other people. With visually striking displays, dynamic taillights convey intentions for braking and turning. Beyond these developments, integrated pedestrian identification and lane departure alerts will soon make roads safer and brighter for everyone.
Luxurious automobile lighting creates a distinct visual identity that goes beyond simple illumination. Personalized interior lighting customizes the driving experience by setting the mood with a range of colours and intensities, while intricate designs and distinctive DRLs modify exteriors. As you approach your automobile at night, welcoming lights lead the way, resulting in an interior that is perfectly lit. Not only is this symphony of light aesthetically pleasing, but it also stands as a tribute to luxury. Upcoming developments like gesture-controlled lighting and holographic displays promise to further enhance the experience.
The worldwide automotive lighting market is undergoing a significant transition towards energy-efficient solutions, as environmental concerns gain prominence. LED technology is leading the way, providing a ray of hope for the environment and drivers alike. LED lights beam brighter and use a lot less energy than conventional halogen lamps. There are some tangible advantages to this. For drivers, this translates to increased fuel economy, which lowers petrol prices and lessens reliance on fossil fuels. Greater air quality and a reduction in the transport sector's contribution to climate change are the results of reduced overall emissions.
Although the global automotive lighting business is booming, there are still unknowns. Difficulties impede growth even as innovation propels it with eye catching features like laser beams and adaptable headlights. These technologies are luxury items due to their high cost and difficult integration, which puts producers' abilities to the test. The worldwide patchwork created by unclear legislation limits the potential of innovation. Durability issues persist, particularly when complex systems are subjected to challenging conditions. Ultimately, a lot of drivers still don't fully understand how these improvements can help them. Together, we can overcome these obstacles. The keys to reducing costs are improved production, more seamless integration, and unified regulations. Their full potential can be realized by educating customers about the safety, efficiency, and aesthetic value of these lighting wonders. By working together, we can pave the way for an even brighter and safer future for vehicle lighting.
It is made possible by advanced LED technology, which gives drivers the ability to customize their illumination for the highest level of comfort and flair. Consumers that care about the environment want greener products, and vehicle lighting complies. While solar- and self-powered lighting technologies offer a future powered by clean energy, energy-efficient LEDs lower pollution. The advent of connected lighting systems heralds a new age. Envision automobiles interacting with infrastructure and one another to minimize accidents and enhance traffic efficiency. Integrated headlights with pedestrian recognition provide unmatched safety, while dramatic taillights with eye-catching displays alert onlookers to your intentions. The possibilities are endless in the future. Gesture-controlled interior illumination, holographic displays projected onto the road, and even light fixtures with self-healing capabilities.
Due to laws requiring safety features like headlights, taillights, and brake lights, exterior lighting presently holds the most market share in the vehicle lighting industry. The dominance of this market is partly attributed to advancements in safety-focused technologies such as adaptive headlights and daytime running lights. The market value of external lighting is increased by the quick adoption of technology like LED bulbs and laser lights, which improve performance and aesthetics. Conversely, the interior lighting market is expected to increase at the fastest rate in the upcoming years. Innovations like ambient lighting and technology breakthroughs like LED and OLED displays, driven by consumer demand for comfort and personalisation, open new possibilities. The spread of sophisticated interior lighting systems is further driven by the growing emphasis on safety and the expansion of the luxury car market.
The worldwide vehicle lighting market is currently dominated by halogen because of its more affordable price, advanced technology, and useful illumination. With its dependable supply chain and affordable option for manufacturers and cost-conscious customers, halogen holds the biggest market share. The fastest-growing market right now is LEDs, which are predicted to shortly overtake halogen. The rapid expansion of LEDs is driven by their higher efficiency, longer lifespan, flexibility in design, and technological breakthroughs including enhanced brightness. Because LEDs use less energy and produce fewer emissions and better fuel economy, they are becoming more and more popular in the changing automotive lighting market.
Passenger automobiles rule the worldwide automotive lighting market. The sheer number of passenger cars produced which surpasses that of business vehicles and fuels the need for lighting systems is the primary cause of this popularity. The growing demand for personal automobiles in developing nations is a result of rising disposable income, which in turn drives the rise of the passenger car market. The importance that consumers place on safety and aesthetics elements helps to drive market expansion. But in the upcoming years, the market for electric and hybrid cars is expected to develop at the quickest rate. The exponential rise of the worldwide electric car market, which is still expanding and shows no signs of slowing down, is what is driving this surge. Specialised lighting solutions are required since electric and hybrid vehicles have different lighting requirements because of their specific functionality and design aesthetics.
Most lighting systems sold nowadays are sold by OEMs (Original Equipment Manufacturers), primarily because manufacturers pre-install lighting systems in new cars. But in the next years, the aftermarket is expected to develop at the quickest rate. This spike in demand for replacement parts, especially lighting systems, can be linked to several variables, one of them being the average age of cars. The industry is expanding because of consumers' growing desire to personalise their cars with aftermarket lighting upgrades such LED upgrades and decorative lighting. The availability and affordability of technologies like adaptive headlights and laser lights in the aftermarket, together with other advancements in lighting technology, are driving demand even more. Moreover, the growing market for electric cars (EVs).
Throughout the forecast period, Asia Pacific is anticipated to be the automotive lighting market with the highest profitability. Over the past few years, Asia Pacific countries like China and India have seen notable increases in automotive manufacturing and sales, primarily in the medium-to premium luxury car segment. Asia Pacific is predicted to see an increase in the manufacturing of passenger cars, with India experiencing the strongest growth rate. Depending on the state of the national economy, the area offers a suitable selection of both high-end and cheap cars. For instance, there is a substantial demand for halogen, Xenon/HID, and LED since China and India produce more economy and mid-range automobiles. On the other hand, luxury car adoption rates are greater in South Korea and Japan, where LED lighting is the norm.
A brief shadow was thrown by COVID-19 over the worldwide automotive lighting market. Production was stopped by lockdowns and supply chain disruptions, while luxury lighting upgrades were shelved by consumers on a tight budget. Resources became scarce, and R&D stagnated. Still, the market is recovering thanks to resurgent demand and rearranged priorities. While energy-efficient LEDs are being pushed towards adoption by sustainability, safety concerns are driving interest in features like pedestrian detection and adaptive headlights. The digital push of the epidemic creates opportunities for intelligent, networked lighting systems that may interact with infrastructure and other cars. Ultimately, the industry is positioned to shine brighter, focused on safety, sustainability, and a connected future, even though the pandemic dimmed its brilliance.
A development collaboration between OSRAM Continental and REHAU aims to incorporate lighting into external components, providing automobile manufacturers with innovative lighting options that improve functionality and design flexibility. For rear combination lamps, Hella unveiled a revolutionary lighting innovation called Hella FlatLight technology. A Memorandum of Understanding (MoU) was signed by Samvardhana Motherson Automotive Systems Group BV (SMRPBV), a division of Motherson Group, and Marelli Automotive Lighting to investigate a technology collaboration focused on intelligently lighted external body components. Valeo debuted their revolutionary 360° lighting system at the Shanghai Auto Show. This technology surrounds the car with a band of light, projecting instantaneous, clear signs that other drivers can see from a distance. Pedestrians, cyclists, and scooter riders are especially susceptible to these signals
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
Specify your preferred Countries, Segments, or timeframes
Unlock Country Level Outlook, Trends, Cross-country Comparability, or supply Chain Variations.
Analyst Support
Every order comes with Analyst Support.
Customization
We offer customization to cater your needs to fullest.
Verified Analysis
We value integrity, quality and authenticity the most.
